Navigation Links
Cyberonics Reports Record Fiscal 2014 Second Quarter Results
Date:11/21/2013

answer session.

The conference call will be available to interested parties through a live audio webcast in the Investor Relations section of Cyberonics' corporate website at http://www.cyberonics.com.  To listen to the conference call live by telephone, dial 877-638-4557 (if dialing from within the U.S.) or 914-495-8522 (if dialing from outside the U.S.).  The conference ID is 74273779. 

Within 24 hours of the webcast, a replay will be available under the "Events & Presentations" section of the Investor Relations portion of the Cyberonics website, where it will be archived and accessible for approximately 12 months.

About Cyberonics, Inc. and the VNS Therapy® SystemCyberonics, Inc. is a medical technology company with core expertise in neuromodulation.  The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression.  The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the vagus nerve.  Cyberonics offers the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics and the VNS Therapy System is available at www.cyberonics.com.

Safe harbor statementThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.  These statements can be identified by the use of forward-looking terminology, including "may," "believe," "will," "expect," "anticipate," "estimate," "plan," "intend," "forecast," or other similar words.  Statements contained in this press release are based on information presently available to us and assumptions that we believe to be reasonable.  We are not assuming any duty to upd
'/>"/>

SOURCE Cyberonics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Cyberonics To Report Fiscal Year 2013 First Quarter Results And Host Conference Call On August 28, 2012
2. Cyberonics To Present At Morgan Stanley 2012 Global Healthcare Conference
3. Cyberonics To Participate In Upcoming September Investor Conferences
4. Cyberonics Announces Investment In cerbomed GmbH
5. Cyberonics To Report Fiscal Year 2013 Second Quarter Results And Host Webcast And Conference Call On November 16, 2012
6. Cyberonics To Present At The 24th Annual Piper Jaffray Healthcare Conference
7. Free Research Report on Laboratory Corp. of America Holdings, Sony Corp., Cyberonics, Inc., Olin Corp. and Deluxe Corp.
8. Cyberonics Announces Update On Hagerty Lawsuit
9. Cyberonics to Participate in Upcoming Investor Conferences
10. Cyberonics To Report Fourth Quarter And Fiscal Year 2013 Results And Host Webcast And Conference Call On June 5, 2013
11. Cyberonics To Report Fiscal Year 2014 First Quarter Results And Host Webcast And Conference Call On August 22, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , Sept. 4, 2015  Luminex Corporation (NASDAQ: ... the Morgan Stanley Global Healthcare Conference to be held ... Hotel in New York City . ... a.m. Eastern time on Friday, September 18, 2015.  The ... Luminex Corporation,s website at http://www.luminexcorp.com . Simply log on ...
(Date:9/4/2015)... , September 4, 2015 ... by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) by ... and by Product - Global Forecast to 2020", published ... reach USD 2.5 Billion by 2020, growing at a ... to 2020. Browse 139 Tables and ...
(Date:9/4/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... Rodman & Renshaw 17 th Annual Global Investment ... New York City .  Dr. Michael Berelowitz ... on September 9, 2015. Presentation Details: ...
Breaking Medicine Technology:Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference 2Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3
... UPI ), a medical device company ... to treat voiding dysfunctions, today announced that Noridian ... both regional Medicare carriers, now cover percutaneous, posterior ... Neuromodulation System for the treatment of the symptoms ...
... was voted the most powerful person in healthcare by readers ... business news magazine. It,s the second consecutive year Obama topped ... in Healthcare. "The passage of national healthcare reform ... Modern Healthcare Editor David Burda. "The Patient Protection ...
Cached Medicine Technology:Coverage Initiated by Two Regional Medicare Carriers for Posterior Tibial Nerve Stimulation (PTNS) Delivered Via Uroplasty's Urgent® PC Neuromodulation System 2Coverage Initiated by Two Regional Medicare Carriers for Posterior Tibial Nerve Stimulation (PTNS) Delivered Via Uroplasty's Urgent® PC Neuromodulation System 3Obama Named the Most Powerful Person in Healthcare for Second Consecutive Year 2
(Date:9/4/2015)... , ... September 04, 2015 , ... According to an ... developed that changes color when subjected to an impact force that is great enough ... implemented in helmets or other sporting equipment so that coaches or officials would instantly ...
(Date:9/4/2015)... ... September 04, 2015 , ... The Schmidt National Law Group filed an ... , Schmidt National Law Group, a leading firm in mass-tort litigation, has filed ... Corp., Bayer Essure, Inc., and other Bayer affiliates for injuries alleged to have been ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... Health Products Association (CHPA) joint meeting of its Product, Quality and Manufacturers, Dietary ... waste handling rules constantly evolving in the consumer goods industry, it can be ...
(Date:9/4/2015)... ... September 04, 2015 , ... “Getting away from the daily stressors and distractions ... and strengthen their ‘couple-ness,’” says Jean Claude Wietzel, general manager at Four Seasons ... the island’s only Forbes Five Star resort and Travel + Leisure’s No. 1 Hotel ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... the microbiome taking place in Hollywood, Florida October 9-10, 2015 at the Diplomat ... at the 2015 symposium are doctors and researchers at the top of their ...
Breaking Medicine News(10 mins):Health News:New Article on Head Injury Detection Technology Highlights Implications for Head Injury Detection in Sports, says The Law Offices of Burg & Brock 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2
... Environmental Protection Agency,s process of generating risk assessments -- ... chemicals found in the environment in order to protect ... and as a decision-making tool it is often hindered ... information needs of officials, says a new report from ...
... Unprecedented Cuts of 27% Will Result in Service Reductions , ... Members of the Council for Quality Respiratory Care (CQRC) -- an ... care for nearly half of Medicare,s home oxygen beneficiaries -- are ... benefit beginning on January 1, 2009. , ...
... manufacturers should,start initiating strategies now to comply with the ... that take effect in March,2010, a newly released Nerac ... "At stake is maintaining or increasing share in ... percentage of most U.S. medical device,companies, profits," write Nerac ...
... PITTSBURGH, Dec. 3 InteGreat, a MED3OOO company ... multi-specialty,clinics, recently entered into a 14-year Application Service ... electronic medical record,systems for the physicians in the ... The WVVA Healthcare Alliance is made up of ...
... study finds , , WEDNESDAY, Dec. 3 (HealthDay News) -- ... of life, they don,t reduce the need for inhalers, ... University of Aberdeen study included nearly 200 adults being ... (94) of the patients did three sessions of breathing ...
... are aimed at combating less responsible uses, claims, experts ... Expensive, sham stem cell therapies are being hawked directly ... In response, the leading organization of stem cell scientists ... field toward responsible, practical uses. , "Stem cell research ...
Cached Medicine News:Health News:EPA's risk assessment process bogged down by unprecedented challenges; 2Health News:EPA's risk assessment process bogged down by unprecedented challenges; 3Health News:EPA's risk assessment process bogged down by unprecedented challenges; 4Health News:Home Oxygen Community Braces for Massive Cuts to Medicare's Home Oxygen Benefit Starting January '09 2Health News:Home Oxygen Community Braces for Massive Cuts to Medicare's Home Oxygen Benefit Starting January '09 3Health News:New Requirements of EU Medical Device Directive Need Immediate Action, Nerac Analysts Urge in Newly Published White Paper 2Health News:New Requirements of EU Medical Device Directive Need Immediate Action, Nerac Analysts Urge in Newly Published White Paper 3Health News:WVVA HealthCare Alliance Signs 14-Year ASP EHR Agreement 2Health News:WVVA HealthCare Alliance Signs 14-Year ASP EHR Agreement 3Health News:WVVA HealthCare Alliance Signs 14-Year ASP EHR Agreement 4Health News:Bogus Stem Cell Therapies Sold on Internet 2Health News:Bogus Stem Cell Therapies Sold on Internet 3
For the quantitative in vitro determination of Microalbumin in human urine....
Determination of Reptilase Time.Extracted venom of Bothrops atrox. 20 BU (Batroxobin unit) per vial....
Quantitative determination of Fibrinogen by STA Analyzers (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Activated Partial Thromboplastin Time (APTT) by STA Analyzers. Cephalin reagent with particulate (silica) activator....
Medicine Products: